Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

VentriPoint Diagnostics Ltd

VPT.V ✓ COMPLIANT ☆ Track — members

TSX Venture · Healthcare · Advanced Medical Equipment & Technology ·

Canada Micro Cap Analyst: N/A

Last Close

$0.08

▲ +5.00%

Market Cap $14.53M · Vol 20.94K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$14.53M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

40.00

Momentum

Beta

0.02

vs Market

52W High

$0.14

45.87% below

52W Low

$0.06

32.41% above

Volume

20.94K

Avg 103.65K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

98.38%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, VentriPoint Diagnostics Ltd (VPT.V) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does VPT.V pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+5.00%

-30.00%

-12.50%

YTD

-25.00%

-8.70%

-62.16%

-74.07%

Financials & Valuation

TTM · Annual

Total Revenue	$66.18K
Net Income	$-3,421,120.00
Revenue Growth (YoY)	+61.69%
Gross Margin	100.00%
Operating Margin	-5,045.41%
Net Profit Margin	-5,169.14%
ROE	N/A
ROA · ROIC	-393.72% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	166.31
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	192.78M

Technical Indicators

50-Day SMA	$0.08
200-Day SMA	$0.08
RSI (14)	40.00
Beta	0.02
52-Week High	$0.14
52-Week Low	$0.06

Volume Today	20.94K
Avg Daily Volume (30D)	103.65K
Relative Volume	0.20x
Volatility (10D)	40.95
Volatility (30D)	77.23
Free Float	98.38%

Analyst Consensus

N/A

Current Price $0.08

Mean Target N/A

52W Low$0.06 52W High$0.14

Current

Target

$0.06 $0.14

Current Analyst target

· 0 analysts

Identifiers

ExchangeTSX Venture

FIGIBBG001S9ML79

ISINCA92281P2008

CountryCanada

Sub-IndustryAdvanced Medical Equipment & Technology (NEC)

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

TMO Thermo Fisher Scientific Inc -1.28% DHR Danaher Corp -0.71% ISRG Intuitive Surgical Inc -1.68% BSX Boston Scientific Corp +0.27% EW Edwards Lifesciences Corp -1.04%

Company Profile

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.